Cutaquig

(immunoglobulin G)
10 ML immune globulin subcutaneous (human) - hipp 165 MG/ML Injection [Cutaquig]12 ML immune globulin subcutaneous (human) - hipp 165 MG/ML Injection [Cutaquig]
View 4 more

Dosage & administration

For subcutaneous use only

Before switching to CUTAQUIG, obtain the patient’s serum IgG trough level to guide subsequent dose adjustments.

Dose

Switching from Immune Globulin Intravenous (IGIV) to CUTAQUIG: calculate the dosing by using a dose conversion factor (1.30); Switching from other Immune Globulin Subcutaneous (IGSC): dosing should be the same as for previous IGSC.

Weekly: Start CUTAQUIG one week after last IGIV infusion

Initial weekly dose = Previous IGIV dose (in grams) x 1.30

No. of weeks between IGIV doses

Every other week: Start CUTAQUIG 1 or 2 weeks after the last IGIV dosing or 1 week after the last IGSC administration. Infuse twice the calculated weekly dose.

More frequent than weekly (2-7 times a week): start CUTAQUIG 1 week after last IGIV or IGSC administration. Divide the calculated weekly dose by the desired number of infusions per week.

Adjust dosing according to patient’s pharmacokinetics and clinical response. (see Dose Adjustment)

Administration :

Administer at regular interval from daily up to every other week. Infusion rate and infusion volume per site may gradually be increased every 2-4 weeks as tolerated by patients.

Infusion sites: up to 6 infusion sites simultaneously, with at least 2 inches between sites. Rotate sites for each administration.

Refer to section 2.3 of full prescribing information for infusion parameters.

drug label

Cutaquig prescribing information

Have more Cutaquig questions?

Submit MSL Request
Learn More

Need to report a Cutaquig issue?

ONLINE FORM
Report adverse event
Learn More

prior authorization

Cutaquig Prior authorization resources

NOT PROVIDED BY BRAND
Complete Letter of Medical Necessity

NOT PROVIDED BY BRAND
Coverage Authorization Request

NOT PROVIDED BY BRAND
Coverage Authorization Appeals
Learn More

Benefits investigation

NOT PROVIDED BY BRAND
Benefits investigation resources
Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRAND
Reimbursement help (FRM) resources
Learn More

financial assistance

Cutaquig Financial assistance options

Co-pay savings program

commercial only
Enroll in a copay savings program
Learn More

Bridge program

commercial only
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+
Learn More

patient education

Cutaquig Patient education

Getting started on Cutaquig

NOT PROVIDED BY BRAND
Instructions for Use - Primary Humoral Immunodeficiency (PI)

Patient toolkit

About Cutaquig
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

Can't find what you're looking for?

Our trained staff can help you:
Please note:
  • Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
  • Samples are provided at the discretion of the brand.
  • We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.